Leatt Corporation Lists on the Pink Sheets Quotation Service
Leatt Corporation (Pink Sheets – LEAT), headquartered in Cape Town, South Africa, announced today that it has obtained a listing on the U.S. Pink Sheets quotation service with the ticker symbol “LEAT”.
Las Vegas, NV, August 23, 2005 --(PR.com)-- Leatt Corporation (Pink Sheets – LEAT), headquartered in Cape Town, South Africa, announced today that it has obtained a listing on the U.S. Pink Sheets quotation service with the ticker symbol “LEAT”.
The Leatt Corporation is the exclusive global developer and distributor of the Leatt-Brace™, a Prophylactic Neck Brace designed to prevent potentially devastating motor sport injuries to the cervical spine (neck). The inventor of the brace, Dr. Chris Leatt, is the President of the Leatt Corporation and is responsible for executing the company’s global strategy. Dr. Leatt is a qualified medical doctor with experience in trauma and neurosurgery.
After serving as the Chief Medical Officer at many South African races over the past years, Dr. Chris Leatt has recently been appointed as Injury Assessment Officer for Motorsport South Africa, which further enables him to analyze the very type of injuries that he seeks to prevent with the introduction of the Leatt-Brace™ and associated products.
The Leatt-Brace™ has been under development and testing for the past three years. Extensive crash testing has been conducted at the Eurotype Test Center located at the South African Bureau of Standards (SABS, http://www.dti.gov.za/thedti/sabs.htm) and the product has undergone more than two years worth of real world testing by racers who have agreed to help develop the brace by providing their valuable feedback.
For more information on the Company and its products, please visit the company website at www.leatt-brace.com. The contents of any referenced Web Site or links therein are expressly not incorporated into this press release.
Legal Notice Regarding Forward-Looking Statements: "Forward-looking statements'' as defined in the Private Securities Litigation Reform Act of 1995 may be included in this news release. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. The Leatt Corporation disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to risks associated with changes in general economic and business conditions, actions of our competitors, the extent to which we are able to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our services, and changes in our business strategies. Other risk factors include, without limitation, the limited resources of the company and the substantially greater resources of competitors, the Company’s status as a penny stock company and a start-up concern without a proven track record in product sales or acceptance of its products by the market, the limitations on liquidity of an investment in Pink Sheet stocks, potential product liability exposure for its products and other risk factors identified in the Company’s present and future public disclosures.
Investor Relations:
Please contact investorrelations@fastmail.fm or call +1 (561) 892 2729
###
The Leatt Corporation is the exclusive global developer and distributor of the Leatt-Brace™, a Prophylactic Neck Brace designed to prevent potentially devastating motor sport injuries to the cervical spine (neck). The inventor of the brace, Dr. Chris Leatt, is the President of the Leatt Corporation and is responsible for executing the company’s global strategy. Dr. Leatt is a qualified medical doctor with experience in trauma and neurosurgery.
After serving as the Chief Medical Officer at many South African races over the past years, Dr. Chris Leatt has recently been appointed as Injury Assessment Officer for Motorsport South Africa, which further enables him to analyze the very type of injuries that he seeks to prevent with the introduction of the Leatt-Brace™ and associated products.
The Leatt-Brace™ has been under development and testing for the past three years. Extensive crash testing has been conducted at the Eurotype Test Center located at the South African Bureau of Standards (SABS, http://www.dti.gov.za/thedti/sabs.htm) and the product has undergone more than two years worth of real world testing by racers who have agreed to help develop the brace by providing their valuable feedback.
For more information on the Company and its products, please visit the company website at www.leatt-brace.com. The contents of any referenced Web Site or links therein are expressly not incorporated into this press release.
Legal Notice Regarding Forward-Looking Statements: "Forward-looking statements'' as defined in the Private Securities Litigation Reform Act of 1995 may be included in this news release. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. The Leatt Corporation disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to risks associated with changes in general economic and business conditions, actions of our competitors, the extent to which we are able to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our services, and changes in our business strategies. Other risk factors include, without limitation, the limited resources of the company and the substantially greater resources of competitors, the Company’s status as a penny stock company and a start-up concern without a proven track record in product sales or acceptance of its products by the market, the limitations on liquidity of an investment in Pink Sheet stocks, potential product liability exposure for its products and other risk factors identified in the Company’s present and future public disclosures.
Investor Relations:
Please contact investorrelations@fastmail.fm or call +1 (561) 892 2729
###
Contact
Leatt Corporation, Inc.
Gregory Allum
+1 702 447 6751
www.leatt-brace.com
Gregory Allum
+1 702 447 6751
www.leatt-brace.com
Contact
Categories